Press Releases

05.06.2020
Iveric Bio Reports First Quarter 2020 Operational Highlights and Financial Results
05.04.2020
Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04.28.2020
Iveric Bio to Report First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 6, 2020
04.03.2020
Iveric Bio Announces Fast Track Designation from U.S. FDA for Zimura® for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
04.02.2020
Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03.23.2020
Iveric Bio Appoints Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer
03.18.2020
Iveric Bio Provides Update on the Initiation of the Second Pivotal Clinical Trial Enrollment for Zimura® in Patients With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
03.03.2020
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02.27.2020
Iveric Bio Reports Fourth Quarter and Year End 2019 Operational Highlights and Financial Results
02.26.2020
Iveric Bio to Present at the Cowen and Company 40th Annual Health Care Conference